DD
48
2
MTCH
50
2
DNB
24
2
AKAM
45
2
HST
49
-3
UAL
66
8
PEG
51
-2
CCL
41
-3
FSLR
60
5
BEN
52
10
ILMN
38
2
MPC
52
10
AAL
32
-4
MMC
48
-3
C
46
2
GS
78
2
DTE
40
-2
PYPL
52
5
XRAY
37
2
AXP
74
-3
DD
48
2
MTCH
50
2
DNB
24
2
AKAM
45
2
HST
49
-3
UAL
66
8
PEG
51
-2
CCL
41
-3
FSLR
60
5
BEN
52
10
ILMN
38
2
MPC
52
10
AAL
32
-4
MMC
48
-3
C
46
2
GS
78
2
DTE
40
-2
PYPL
52
5
XRAY
37
2
AXP
74
-3
Financhill
Back

Cincinnati Financial Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

CINF
Cincinnati Financial

Last Price:
113.55
Seasonality Move:
-1.09%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
43.99
Seasonality Move:
10.8%
Sell
41
Cincinnati Financial (CINF) is a Sell

Is Cincinnati Financial a Buy, Sell or Hold?

  • The current Cincinnati Financial [CINF] share price is $110.88. The Score for CINF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CINF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CINF Stock Price Chart

What is Cincinnati Financial's stock price today?

  • The Cincinnati Financial share price today is $110.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CINF is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $44.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CINF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 32.73 Sell
Chaikin Money Flow: -1561340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (116.91 - 122.37) Sell
Bollinger Bands (100): (105.86 - 118.62) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.09 Sell
Relative Strength Index (14 RSI): 43.92 Sell
Chaikin Money Flow: 101540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.49 - 48.87) Sell
Bollinger Bands (100): (43.62 - 49.46) Sell

CINF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 117.98 Sell
20-day SMA: 119.25 Sell
50-day SMA: 117.47 Sell
200-day SMA: 107.77 Buy
8-day EMA: 117.4 Sell
20-day EMA: 118.41 Sell
50-day EMA: 116.92 Sell
200-day EMA: 110.32 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.87 Buy
20-day SMA: 46.21 Sell
50-day SMA: 47.79 Sell
200-day SMA: 42.13 Buy
8-day EMA: 44.35 Sell
20-day EMA: 45.49 Sell
50-day EMA: 46.38 Sell
200-day EMA: 44.57 Sell

Cincinnati Financial Earnings Growth & CINF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.63 per share, and an increase next year of $0.74 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.

Cincinnati Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):